AcrySof™ IQ PanOptix™ Toric UV IOL TFAT30 (REF TFAT30.150)Recalls & reported problems
Alcon Laboratories, Inc. · AcrySof® IQ PanOptix® Toric Trifocal intraocular lenses (IOLs) are ultraviolet absorbing foldable multifocal IOLs · Class 3 · Implant
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00380652418607), received between Oct 20, 2021 and Apr 6, 2023 — classified as 4 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem4
Patient problems
- Blurred Vision2
- Eye Pain2
- Headache2
- Visual Disturbances2
- Visual Impairment2
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- Depression1
- Dry Eye(s)1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryApr 6, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A NON-HEALTHCARE PROFESSIONAL REPORTED THAT AFTER INTRAOCULAR LENS (IOL) IMPLANTATION PROCEDURE, THE PATIENT EXPERIENCED INTOLERABLE HALOS. THE IOL WAS EXPLANTED AND REPLACED WITH A MONOFOCAL LENS IN A SECONDARY PROCEDURE. ADDITIONAL INFORMATION STATED THAT PATIENT'S RIGHT EYE WAS INVOLVED AND THE PATIENT'S ISSUES HAVE BEEN RESOLVED.
Patient problems: Halo
MAUDE report 16689511 ↗InjuryJun 13, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A CONSUMER REPORTED THAT FOLLOWING IMPLANTATION OF AN INTRAOCULAR LENS (IOL) THE PATIENT FACED DIFFICULTIES NOT SURE IF IT IS DUE TO THE LENSES AND MIGHT BE AN ALLERGIC REACTION TO THE LENS MATERIAL. THE PATIENT SYMPTOMS ARE BURNING AND STABBING PAIN, HEADACHES FROM EYE STRAIN, WAVY AND BLURRY VISION, FEELS LIKE SAND IS IN HER EYES, HAS TO WEAR SUNGLASSES BECAUSE OF LIGHT SENSITIVITY, AND THIS HAS ALL AFFECTED HER QUALITY OF LIFE AND AS CAUSED DEPRESSION. PATIENT HAS TRIED DROPS AND OINTMENTS WHICH HAVE CAUSED MORE PAIN AND BELIEVES PATIENT IS ALLERGIC TO THE PRESERVATIVES IN THOSE PRODUCTS. THE DOCTOR SWITCHED HER TO XIIDRA, BUT IT'S NOT HELPING. THE PATIENT HAS BLEPHARITIS. THERE ARE TWO MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS PATIENT. THIS REPORT IS ASSOCIATED WITH THE RIGHT EYE. ADDITIONAL INFORMATION WAS REQUESTED AND RECEIVED.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Blurred Vision; Depression; Dry Eye(s); Eye Pain; Foreign Body Sensation in Eye; Headache; Inflammation; Visual Disturbances
MAUDE report 14672887 ↗InjuryFeb 1, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A NURSE REPORTED THAT AN INTRAOCULAR LENS (IOL) WAS EXPLANTED APPROXIMATELY 4 MONTHS AFTER IMPLANTATION DUE TO PATIENT HAVING HEADACHES, TROUBLE FOCUSING AND CONTRAST PHOTOPHOBIA. ADDITIONAL INFORMATION WAS REQUESTED.
Patient problems: Blurred Vision; Headache; Visual Disturbances; Visual Impairment
MAUDE report 13416712 ↗InjuryOct 20, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A SURGICAL TECHNOLOGIST REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE THE PATIENT STRAINS TO SEE AND SEES TRIPLOPIA. THE IOL WAS EXCHANGED FOR A DIFFERENT MODEL IOL, IN A SECONDARY PROCEDURE. ADDITIONAL INFORMATION RECEIVED STATING THERE WAS NO HARM TO PATIENT AND PATIENT ISSUES WERE RESOLVED.
Patient problems: Eye Pain; Visual Impairment
MAUDE report 12666087 ↗
Other Lens, multifocal intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page